Ureaplasmas are the microorganisms most frequently isolated from the amniotic fluid of pregnant women and can cause chronic intrauterine infections. These tiny bacteria are thought to undergo rapid evolution and exhibit a hypermutatable phenotype; however, little is known about how ureaplasmas respond to selective pressures in utero. Using an ovine model of chronic intraamniotic infection, we investigated if exposure of ureaplasmas to subinhibitory concentrations of erythromycin could induce phenotypic or genetic indicators of macrolide resistance. At 55 days gestation, 12 pregnant ewes received an intraamniotic injection of a nonclonal, clinical Ureaplasma parvum strain followed by (i) erythromycin treatment (intramuscularly, 30 mg/kg/day, n ¼ 6) or (ii) saline (intramuscularly, n ¼ 6) at 100 days gestation. Fetuses were then delivered surgically at 125 days gestation. Despite injecting the same inoculum into all the ewes, significant differences between amniotic fluid and chorioamnion ureaplasmas were detected following chronic intraamniotic infection. Numerous polymorphisms were observed in domain V of the 23S rRNA gene of ureaplasmas isolated from the chorioamnion (but not the amniotic fluid), resulting in a mosaiclike sequence. Chorioamnion isolates also harbored the macrolide resistance genes erm(B) and msr(D) and were associated with variable roxithromycin minimum inhibitory concentrations. Remarkably, this variability occurred independently of exposure of ureaplasmas to erythromycin, suggesting that low-level erythromycin exposure does not induce ureaplasmal macrolide resistance in utero. Rather, the significant differences observed between amniotic fluid and chorioamnion ureaplasmas suggest that different anatomical sites may select for ureaplasma subtypes within nonclonal, clinical strains. This may have implications for the treatment of intrauterine ureaplasma infections. amniotic fluid, chorioamnion, minimum inhibitory concentration, ovine model, ribosomal RNA, ureaplasma
INTRODUCTION
The human ureaplasmas (Ureaplasma parvum and U. urealyticum) are among the smallest self-replicating bacteria, typically ranging in size from 100 nm to 1 lm [1] . They can be isolated from the mucosal surfaces of the vagina or cervix in 40%-80% of sexually active females [2] and are the most frequently isolated microorganisms from infected amniotic fluids and placentas [3] [4] [5] [6] . Although amniotic fluid contains a number of bacteriostatic/bacteriocidal components [7] , ureaplasmas have been detected in the amniotic fluid of pregnant women as early as the 16th wk of pregnancy (in the presence of intact fetal membranes) and have been reported to persist for as long as 2 mo [8] . Furthermore, in a sheep model of intraamniotic infection, we demonstrated that ureaplasmas can colonize the amniotic fluid for up to 85 days [9] . Although often clinically silent, intraamniotic ureaplasma infections stimulate a proinflammatory host response [9, 10] and are associated with histological chorioamnionitis, funisitis, and preterm birth. Ureaplasmas may also colonize the fetus in utero or be vertically transmitted to the infant at birth, and are associated with neonatal diseases, including bronchopulmonary dysplasia, pneumonia, sepsis, and meningitis [11, 12] .
Eradication of intraamniotic ureaplasma infections by antimicrobial treatment is thought to improve pregnancy outcomes and reduce neonatal morbidity and mortality [13, 14] . Erythromycin (a 14-membered lactone ring macrolide) is routinely administered to pregnant women for the treatment of intraamniotic infections and preterm, prelabor rupture of membranes. However, this treatment may be ineffective [15, 16] because there is minimal placental transfer of erythromycin from the maternal circulation to the amniotic fluid. In humans, the placental transfer of erythromycin is as low as 3% [17] , suggesting that microorganisms within the amniotic fluid might only be exposed to low levels of antimicrobials. In an ovine model of intraamniotic ureaplasma infection, we reported that standard-dose maternal erythromycin treatment achieved low concentrations (,10-76 ng/ml) in the amniotic fluid and did not eradicate infection [18] .
Exposure of bacteria to nonlethal concentrations of antimicrobials may promote antimicrobial resistance, which can occur by target site modification, drug efflux pumps, or drug inactivation mediated by short peptides [19] . Mechanisms of macrolide resistance that have been identified in ureaplasmas include target site modification via mutations in the 23S rRNA gene and ribosomal protein L4 and L22 genes [20] [21] [22] . The lactone ring of macrolide antimicrobials interacts hydrophobically with the crevice formed by bases 2057, 2058, and 2059 (Escherichia coli numbering) of the 23S rRNA gene; therefore a mutation in any of these nucleotides may inhibit macrolide binding. Similarly, point mutations in ribosomal protein L4 and L22 genes may also allosterically affect macrolide binding [19] . In addition, erythromycin-ribosome methylase (erm) genes, which posttranslationally methylate nucleotide 2058 of domain V of the 23S rRNA gene to inhibit macrolide binding via steric hindrance, have been reported in ureaplasmas and may be associated with phenotypic resistance [23] . Macrolide resistance may also occur by the activity of drug efflux pumps such as the macrolide streptogramin resistance (msr) genes, which export antimicrobials out of the bacterial cell. Previously, Lu et al. [23] detected msr(A), msr(B), and msr(D) subtypes in Ureaplasma spp. and suggested that they may be associated with ureaplasmal resistance to macrolides and/or lincosamides.
Members of the Mycoplasmataceae family with very small genomes, such as the Ureaplasma spp., exhibit a hypermutatable phenotype and may undergo rapid evolution [24, 25] . Indeed, ureaplasmas undergo significant genetic variability associated with (i) size/phase variation of surface-exposed antigens [26] [27] [28] [29] [30] ; (ii) the presence of hypervariable plasticity zones functioning as putative pathogenicity islands [31] ; and (iii) horizontal gene transfer (HGT) and proposed recombination events resulting in genetic mosaics [32, 33] . Furthermore, point mutations in ureaplasmal 23S rRNA and ribosomal protein L4 and L22 genes can be induced in vitro by passaging isolates in broth medium containing subinhibitory concentrations of macrolide antimicrobials [22] . However, to the best of our knowledge, the effects of low-level antimicrobial exposure on ureaplasmas have not been investigated in vivo.
Using an ovine model of chronic intraamniotic infection, we tested if U. parvum colonizing the amniotic fluid and chorioamnion of pregnant sheep underwent genetic variation following exposure to selective antimicrobial pressure. Specifically, we investigated if exposure of ureaplasmas to subinhibitory concentrations of erythromycin in utero could induce genetic markers of macrolide resistance. By sequencing regions of the ureaplasmal 23S rRNA gene and performing PCRs to detect macrolide resistance genes, we observed significant genetic variability within chorioamnion ureaplasmas following chronic, intraamniotic infection.
MATERIALS AND METHODS

Ethics Statement
All the experimental procedures involving animals were performed in accordance with the Australian code of practice for the care and use of animals for scientific purposes (National Health and Medical Research Council of Australia) and were approved by the Animal Ethics Committee of The University of Western Australia.
Animal Model and Specimen Collection
The inoculum used for intraamniotic injection was a low-passage, erythromycin-susceptible, U. parvum serovar 3 isolate (442S) that was originally isolated from the semen of an infertile man attending the Wesley IVF Service (Brisbane, Queensland). Isolate 442S was selected for this study because it was a nonclonal, clinical strain containing a mixture of ureaplasma subtypes that were adherent and nonadherent to the surface of spermatozoa. A nonclonal strain, as opposed to a clonal ureaplasma strain that had been cloned and filtered in vitro, was chosen to closely model ureaplasmas isolated from natural infections. Ureaplasmas for injection were prepared as previously described and diluted to 2 3 10 4 colony-forming units in PBS prior to intraamniotic injection [34] .
The samples analyzed in this study were collected from a previously described experiment [18] . Briefly, at 55 days gestation (term ¼ 150 days gestation), 12 date-mated Merino ewes bearing single fetuses received a 2 ml intraamniotic injection of U. parvum 442S [34] . At 100 days gestation, the ewes were randomly assigned to receive erythromycin treatment (Up/E group; n ¼ 6) or saline (Up group; n ¼ 6). Ewes that received erythromycin treatment were injected intramuscularly with 500 mg of erythromycin (Abbot Australasia, Kurnell, New South Wales) three times daily for 4 days (i.e., 100-104 days gestation), resulting in a total dose of 30 mg/kg/day. Additional antibiotics were not added to the supplementary feed given to pregnant ewes, nor did animals receive antimicrobial treatment as part of ongoing veterinary care. Preterm fetuses were surgically delivered at 125 days gestation [18] . Samples of amniotic fluid and chorioamnion were aseptically collected and stored at À808C for subsequent analysis.
Ureaplasma Culture
Ureaplasmas were cultured from amniotic fluid and chorioamnion samples collected from each animal. Thawed chorioamnion tissue (0.1 g) was homogenized in 1.5 ml of 10B medium [35] using a mini beadbeater 8-cell disrupter (Daintree Scientific, St. Helens, Tasmania). Homogenized chorioamnion and amniotic fluid samples were then cultured in 10B medium [36] , and positive cultures were stored at À808C for further analysis.
23S rRNA, Ribosomal Protein L4, and Ribosomal Protein L22 PCR and Sequencing
To detect polymorphisms within genes associated with macrolide resistance, PCRs targeting domain II and domain V of the 23 rRNA gene and ribosomal protein L4 gene and ribosomal protein L22 gene were performed on the ureaplasma isolates from the amniotic fluid and chorioamnion. DNA was extracted from first passage cultures in 10B broth using previously described methods [37] . The PCR assays were performed in 50 ll reaction mixtures containing 100 lM of dNTP mix (Roche Diagnostics, Castle Hill, New South Wales), 13 PCR products from U. parvum 442S and representative amniotic fluid (n ¼ 5) and chorioamnion (n ¼ 4) strains were purified using the High Pure PCR Product Purification Kit (Roche Diagnostics). Sequencing reactions were performed by the Australian Genome Research Facility (St. Lucia, Queensland). Sequence data were trimmed to obtain sequences of a uniform length and then aligned using Geneious Pro version 5.6.5. Partial 23S rRNA sequences from representative amniotic fluid and chorioamnion ureaplasma isolates were deposited in GenBank (National Center for Biotechnology Information, Bethesda, MD, 2013) under the accession numbers JF521483, JF521484, JF521485, and JF521486.
PCR for erm(B) and msr Genes
PCRs were performed to detect selected genes associated with macrolide resistance: erm(B), msr(A), msr(B), msr(C), and msr(D) [23, [38] [39] [40] . These assays were performed on isolates selected for 23S rRNA and ribosomal protein L4 and L22 gene sequencing. PCRs were performed in 50 ll volumes as described above, using primers shown in Table 1 . PCR reactions were performed using cycling conditions described by Lu et al. [23] ; however, initial denaturation and final elongation steps were modified to 948C for 15 min and 728C for 15 min, respectively.
Minimum Inhibitory Concentration
The minimum inhibitory concentrations (MICs) of erythromycin (SigmaAldrich), roxithromycin (Sigma-Aldrich), and azithromycin (Pfizer, West Ryde, New South Wales) were determined for ureaplasmas isolated from amniotic fluid and chorioamnion samples at 125 days gestation. Isolates to be tested were thawed and diluted to a standardized concentration of 1 3 10 4 colony-forming units/ml in 10B broth. MICs were determined using standard broth microdilution assays [41, 42] and interpreted according to defined Clinical and Laboratory Standards Institute (CLSI) breakpoints [42] . Each antibiotic was tested in triplicate, and MIC results are expressed as the mean value of the three experiments.
Statistical Analysis
Statistical analyses were performed using GraphPad Prism version 5.0. A two-tailed Fisher exact test was used to compare the proportion of amniotic fluid and chorioamnion ureaplasma isolates harboring macrolide resistance DANDO ET AL.
genes. MIC data were compared between Up and Up/E groups using independent, two-tailed t-tests.
RESULTS
Intraamniotic Ureaplasmas Caused Chronic Intrauterine Infection
Injection of U. parvum into the amniotic fluid of pregnant ewes at 55 days gestation resulted in chronic intrauterine infection. At 125 days gestation, ureaplasmas were isolated from six of six amniotic fluid samples (100%) and four of six chorioamnion samples (67%) collected from the Up group. Maternal erythromycin treatment (Up/E group) did not eliminate ureaplasma colonization within the amniotic fluid (6 of 6 [100%] culture positive) and chorioamnion (4 of 6 [67%] culture positive) at 125 days gestation. Quantitative bacterial cultures from these amniotic fluid and chorioamnion samples were reported in a previous publication [18] . First passage cultures were stored at À808C and used for DNA extraction and MIC testing.
23S rRNA Gene Sequence Variability in Ureaplasmas Isolated from the Chorioamnion
The maternal administration of erythromycin resulted in subinhibitory antimicrobial levels within the amniotic fluid in pregnant sheep [18] . To determine if ureaplasmas exposed to subinhibitory concentrations of erythromycin in utero demonstrated genetic markers of antimicrobial resistance, PCR was performed to amplify domains II and V of the 23S rRNA gene and the genes encoding ribosomal protein L4 and ribosomal protein L22 (data not shown). Amplicons from amniotic fluid and chorioamnion ureaplasma isolates and U. parvum isolate 442S were then sequenced. Within each of the sequenced regions, U. parvum isolate 442S shared 100% sequence identity with the U. parvum serovar 3 reference strain (ATCC 700970; Genbank accession number AF222894). No sequence polymorphisms were detected in any of the ureaplasmas, which were isolated from amniotic fluid samples, across any of the targeted regions of the 23S rRNA gene and the L4 and L22 ribosomal protein genes. Hence, all amniotic fluid isolates shared 100% sequence identity with the U. parvum serovar 3 reference strain and isolate 442S (the inoculum).
Conversely, significant genetic variability was detected within all ureaplasma isolates from the chorioamnion, when compared to amniotic fluid ureaplasma isolates, U. parvum ATCC 700970, and U. parvum 442S (Table 2) . These polymorphisms occurred independently of exposure to erythromycin as they were detected in chorioamnion isolates from both the Up and Up/E groups. The regions of genetic variability were localized within domain V of the 23S rRNA gene, specifically within the regions amplified by PCR primers MH23S-11/MP23S-22 and MH23S-9/MP23S-23. Within the region amplified by the primer pair MH23S-11/MP23S-22, 72 identical polymorphisms, five insertions, and five deletions (out of 230 sequenced nucleotides) were detected in each chorioamnion ureaplasma isolate. Similarly, within the region of domain V of the 23S rRNA gene amplified by PCR primer MH23S-9/MP23S-23, 36 identical polymorphisms (out of 200 nucleotides) were detected. Within these polymorphic regions, a higher GþC content were also observed ( Table 2) . Gene alignments demonstrating the significant sequence variability between chorioamnion and amniotic fluid ureaplasma strains are shown in Figure 1 Despite the large number of polymorphisms detected in chorioamnion ureaplasma strains, specific nucleotides that were previously associated with macrolide resistance in ureaplasmas and other bacteria (nucleotides G2056, G2057, and A2058 of domain V of the 23S rRNA gene, E. coli numbering [22] , and C2243, U. urealyticum numbering [21] ) remained conserved. No polymorphisms were detected in domain II of the 23S rRNA gene or ribosomal proteins L4 and L22. The macrolide resistance gene erm(B) was not detected in any ureaplasmas isolated from the amniotic fluid, but was present in U. parvum 442S and 100% of ureaplasmas isolated from the chorioamnion (P ¼ 0.008; Fig. 3A ). Of the four tested msr gene subtypes, msr(D) was the only gene detected in the ureaplasma isolates (Fig. 3B) ; msr(D) was detected in U. parvum 442S, two of five amniotic fluid ureaplasma isolates (40%), and 100% of chorioamnion ureaplasma isolates (P , 0.05). The presence of macrolide resistance genes occurred independently of exposure to erythromycin because erm(B) and msr(D) genes were detected in ureaplasmas from both the Up and Up/E groups.
23S rRNA Genetic Variability and erm(B) and msr(D)
Genes Were Not Associated with Phenotypic Resistance to Macrolide Antimicrobials
The inoculum strain used for this animal study, U. parvum strain 442S, was susceptible to erythromycin, azithromycin, and roxithromycin, with MIC values of 0.13, 0.5, and 0.5 mg/L respectively. Ureaplasmas isolated from the amniotic fluid after 125 days gestation also demonstrated susceptibility to erythromycin, azithromycin, and roxithromycin (Table 3) . The MICs of these three antimicrobials were not different when tested against amniotic fluid ureaplasmas isolated from the Up group and the Up/E group (P . 0.05).
Although ureaplasmas isolated from the chorioamnion demonstrated (i) significant genetic variability within domain V of the 23S rRNA gene and (ii) the presence of erm(B) and msr(D) resistance genes, these isolates were not phenotypically resistant to the tested macrolide antimicrobials ( Table 3 ). The MICs of erythromycin and azithromycin against ureaplasmas isolated from the chorioamnion were low, ranging from 0.06 to 0.25 mg/L, whereas the MICs of roxithromycin were variable against chorioamnion ureaplasmas, ranging from 0.13 to 5.33 mg/L. However, according to the defined CLSI breakpoints, none of the chorioamnion ureaplasma isolates were resistant to roxithromycin. The MICs of erythromycin, azithromycin, and roxithromycin were not statistically different between ureaplasmas isolated from the chorioamnion from the Up group and the Up/E group (P . 0.05).
DISCUSSION
We investigated whether low-level erythromycin exposure could induce genetic markers of macrolide resistance in ureaplasmas isolated from the amniotic fluid and chorioamnion of pregnant sheep at 125 days gestation. Subinhibitory erythromycin concentrations were achieved in the amniotic fluid via maternal intramuscular erythromycin treatment at 100-104 days gestation [18] . Previous studies have suggested that ureaplasmas are highly variable and undergo rapid evolution [24, 25] ; therefore, we hypothesized that the application of selective antimicrobial pressure for a short period of time (4 days) may be sufficient to generate genetic variants. We assessed this by performing PCR and sequencing of domains II and V of the ureaplasmal 23S rRNA gene and ribosomal protein L4 and L22 genes. Mutations in these genes were previously associated with macrolide resistance in ureaplasmas [20] [21] [22] . We detected significant genetic variability, including nucleotide substitutions, insertions, and deletions, within domain V of the 23S rRNA gene; however, this variability did not occur in response to erythromycin treatment. Rather, genetic variability within the 23S rRNA gene was detected exclusively in ureaplasmas isolated from the chorioamnion following chronic intrauterine infection and was present in ureaplasmas isolated from both the treatment and the control group animals.
Genetic diversity was detected within two regions of domain V of the 23S rRNA gene, amplified by two separate primer pairs. U. parvum possesses two ribosomal operons, both of which were amplified simultaneously by the primers used in this study. Sequence chromatograms did not reveal double peaks at any loci, indicating that both copies of the 23S rRNA gene were identical. Marques et al. [43] previously reported intraspecific sequence variation of the 16S rRNA gene of the bovine pathogen U. diversum. In their study of 34 field isolates, four hypervariable regions within the 16S rRNA gene were identified, and within these regions, 44 polymorphisms were detected. Furthermore, an isolate with only 88% sequence similarity to the U. diversum 16S rRNA reference sequence was identified. In the present study, across the two variable regions of domain V of the 23S rRNA gene, ureaplasmas isolated from the chorioamnion shared only 78% sequence similarity with the U. parvum 442S inoculum strain.
Because of (i) the presence of identical polymorphisms in chorioamnion ureaplasma strains and (ii) the increased GþC content of these variable regions, we propose that these regions of genetic variability may represent fragments transferred by HGT. Previous studies have demonstrated that ureaplasmas undergo extensive HGT resulting in genetic mosaics, which arise from proposed recombination events [32, 33] . U. parvum isolate 442S, the nonclonal inoculum strain, was characterized in our laboratory and found to contain a mixed population of DANDO ET AL.
ureaplasmas with different phenotypic properties [44] . We suggest that this strain may also contain a small population of 23S rRNA genetic variants, which were generated via previous HGT events. However, sequencing of domain V of the 23S rRNA gene of isolate 442S did not detect the variant sequence nor were double peaks observed at any loci. Xiao et al. [32] demonstrated that mixed populations of ureaplasmas could not be detected by Sanger sequencing once the DNA concentration IN UTERO SELECTION OF U. PARVUM VARIANTS ratio reached 9:1. Thus, it is likely that the variant sequence is present only in a small, undetectable population of ureaplasmas within isolate 442S, which were subsequently selected for in the chorioamnion during chronic intraamniotic infection. Previous studies have shown that the host immune response and host genetic background affect the outcomes of ureaplasma infection [9, 45] . Here, we have demonstrated that ureaplasma subtypes within a mixed population may be selected for at different anatomical sites within a host, which may also affect outcomes. We are unable to speculate as to which components of the chorioamnion may have resulted in the selection of the variant ureaplasma subtype; however, there are significant differences in the microenviromnent of the amniotic fluid compared to that of the chorioamnion, which may result in different selective pressures between these anatomical sites.
The amniotic fluid is a proteinaceous biological fluid, which undergoes dynamic change throughout pregnancy. Early in gestation, the protein content of amniotic fluid resembles that of maternal serum (albeit at lower concentrations); however, fetal urine is a major component of amniotic fluid in the second half of pregnancy [46] . A proteomic analysis of human amniotic fluid demonstrated that amniotic fluid contained proteins that function in immune defense, cell communication/ transport, metabolism, enzyme activity, signal transduction, development/cell differentiation, cell proliferation, cell organization, and others of unknown function [47] . Although comprehensive proteomic studies of the chorioamnion are lacking, the chorioamnion contains multiple cellular layers, connective tissue, and an extracellular matrix, which is composed largely of collagen [48] . The source of innate 
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immune cells within the amniotic fluid and chorioamnion have also been shown to differ: neutrophils within the chorioamnion are maternally derived, whereas amniotic fluid neutrophils are fetal in origin [49, 50] . Interestingly, Namba et al. [50] demonstrated that sulfoglycolipid, the receptor for Ureaplasma spp., is localized within the amnion, suggesting that the chorioamnion may have selected for adherent ureaplasma subtypes in our study, although this remains to be confirmed.
It is remarkable that identical variant populations were expanded within the chorioamnion of all experimentally infected animals. However, similar findings were previously reported for other microorganisms. In an in vitro model of E. coli evolution, two populations derived from a common ancestor were propagated for 20 000 generations in minimal medium [51] . Identical changes in gene expression were detected in the two independently propagated E. coli populations relative to the ancestral strain, demonstrating parallel evolution and/or selection. In vivo selection of variant populations of Burkholderia pseudomallei has also been demonstrated. Complete genome sequencing of human B. pseudomallei stains isolated during primary infection and following relapse of the primary infection [52] or from persistent asymptomatic carriage [53] showed that strong selection of genetic variants occurred during chronic infection. Tissue-specific selection has also been reported for Pseudomonas aeruginosa and Staphylococcus aureus colonizing the lungs of cystic fibrosis patients [54, 55] . An in silico study of the coding sequences of U. urealyticum and the related microorganisms Mycoplasma genitalium and M. pneumoniae suggested that genetic selection at the codon level for U. urealyticum and M. genitalium is most likely to be driven by environmental stimuli rather than phylogenetic relationships [56] . Here, we provide evidence that different anatomical sites may select for ureaplasma variants and thus alter the sociomicrobiological structure of the bacterial population.
Although chorioamnion ureaplasma isolates demonstrated significant genetic variability within domain V of the 23S rRNA gene, these isolates were not phenotypically resistant to erythromycin, azithromycin, or roxithromycin. Heterogeneity was observed in the MICs of roxithromycin when tested against ureaplasmas isolated from the chorioamnion, with MIC values ranging from 0.13 to 5.33 mg/L. Despite this, according to recently defined CLSI breakpoints, MICs 4 mg/L indicate susceptibility, whereas MICs ! 16 mg/ml indicate resistance to macrolide antimicrobials. Therefore, none of the tested isolates were resistant to the tested macrolides. We also tested the ability of chrorioamnion ureaplasma isolates to form biofilms in vitro; however, biofilm formation was not associated with increased resistance to the erythromycin, azithromycin, or roxithromycin, compared to planktonic chorioamnion ureaplasma isolates (data not shown). Nucleotides that were previously associated with macrolide resistance in ureaplasmas [21, 22] remained conserved in all the tested strains, potentially explaining why ureaplasmas isolated from the chorioamnion were susceptible to macrolides. It is surprising that such significant changes in the sequence of domain V of the 23S rRNA gene were not associated with increased resistance to macrolides as a result of potential changes in the secondary structure of the rRNA. Furthermore, we did not observe any differences in growth rates between ureaplasma isolates containing the wild-type rRNA sequence and those with the variant rRNA sequence (data not shown), suggesting that genetic variability within 23S rRNA did not affect ureaplasmal fitness. This is in agreement with Asai et al. [57] who reported that following inactivation of all seven E. coli chromosomal rRNA operons and insertion of foreign rRNA operons derived from Salmonella typhimurium or Proteus vulgaris, no effects on microbial fitness were observed. Collectively, these data demonstrate that bacteria may swap fragments or entire rRNA operons via HGT without significant impact on survival.
We also performed PCR for the amplification of macrolide resistance genes, including erm(B), msr(A), msr(B), msr(C), and msr(D). Previously, Lu et al. [23] characterized macrolideand lincosamide-resistant ureaplasma strains and reported that ureaplasmas harboring the erm(B) gene were associated with erythromycin MICs ranging from 8 to !128 mg/L. The presence of erm(B) was also significantly associated with the int-Tn gene, which is a genetic marker of a transposon, and it was suggested that erm(B) may be part of a ureaplasmal transposon. Here, we detected erm(B) in isolate 442S and all IN UTERO SELECTION OF U. PARVUM VARIANTS chorioamnion ureaplasma isolates, but not in any ureaplasmas isolated from the amniotic fluid. This provides further evidence that a variant ureaplasma population within isolate 442S was selected for within the chorioamnion. In contrast to Lu et al. [23] , in our study, erm(B) was not associated with phenotypic resistance to macrolides. We also detected msr(D) in isolate 442S, 40% of amniotic fluid ureaplasmas, and 100% of chorioamnion ureaplasmas. Similar to previous findings in which msr(D) was associated with very wide MIC ranges and did not always confer a resistant phenotype [23] , our data demonstrated that the presence of msr(D) was not associated with macrolide resistance. Interestingly, the msr(D) PCR produced additional faint bands in chorioamnion ureaplasma isolates that were not present in amniotic fluid ureaplasmas or isolate 442S. We were unable to identify these bands; however, we speculate that the genetic changes selected for in chorioamnion ureaplasmas may contain multiple msr(D) primer binding sites that are not present in the amniotic fluid isolates or the inoculum strain. Further research is required to characterize the role of the erm and msr genes in ureaplasmas.
A limitation of our study is that ureaplasmas were injected directly into the amniotic fluid of pregnant sheep; therefore the model does not represent the progression of an ascending invasive infection from the lower genital tract, which is predicted to be a common mechanism of intraamniotic infection. Ascending infections occur when vaginal microorganisms cross the cervix, ascend into the choriodecidual space, and then cross the chorioamnion and enter the amniotic fluid [58] . However, upper genital tract infections may also arise due to iatrogenic needle contamination at the time of amniocentesis or chronic villus sampling or hematogenous spread through the placenta [58] . Furthermore, ureaplasmas may also access the female upper genital tract by attachment to the surface of spermatozoa [44] , or they may be present in the endometrium of healthy, nonpregnant females [11] . Thus ureaplasmas may colonize the amniotic fluid and chorioamnion by mechanisms other than ascending invasive infections.
In summary, in vivo exposure of a nonclonal, clinical ureaplasma strain to subinhibitory levels of erythromycin did not induce genetic markers of macrolide resistance. However, we demonstrated significant differences between ureaplasmas isolated from the amniotic fluid and chorioamnion following chronic intrauterine infection in a sheep model, with respect to 23S rRNA gene sequence and the presence of macrolide resistance genes. These findings suggest that different anatomical sites may select for variant populations within a nonclonal ureaplasma strain and may have several implications. First, the significant genetic differences between amniotic fluid ureaplasmas and chorioamnion ureaplasmas support previous studies suggesting that ureaplasmas undergo HGT, which may result in the lateral transfer of antibiotic resistance genes, virulence genes, or genes required for survival in niche environments. Second, the selection of variant ureaplasma subtypes at different anatomical sites suggests that intrauterine ureaplasma infections are highly complex and that amniotic fluid cultures alone may not isolate ureaplasmas that are representative of the entire population present within the fetal compartment. Clinically, this becomes important when considering antimicrobial susceptibility testing and treatment, and may explain why ureaplasma infections can be difficult to eradicate. Third, these findings also have implications for our understanding of ureaplasmal pathogenesis because ureaplasma subtypes localized within the chorioamnion and amniotic fluid may be associated with differences in virulence and differences in the severity of in utero inflammation, which have been observed previously in an animal model [29, 30] . Although not examined in this study, in a previous experiment using the same inoculum strain (isolate 442S), we demonstrated that ureaplasmas isolated from the chorioamnion of pregnant sheep produced a significantly different multiple banded antigen profile compared to ureaplasmas isolated from the amniotic fluid and fetal lung [30] . This provides further evidence that the amniotic fluid and chorioamnion may select for different ureaplasma subtypes within a mixed population. The data presented in this study demonstrate that, similar to related Mycoplasmas spp., ureaplasma populations are dynamic and are influenced by the local microenvironment. DANDO ET AL.
